Axsome Therapeutics, Inc. — insider transactions
6 transactions on record · CIK 1579428
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
6
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$10.8M
Median disclosure lag
1.5 d
trade date to filing date
Largest single trade, 24m
$9.5M
2026-08-05
Director share, 12m
100.0%
of transactions where role is stated
Current run
6 sells
consecutive same-direction transactions
Net 3m flow
-$10.8M
purchases minus sales
Total on record
6
Transactions
6 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | 2026-08-06 | 1 | TABUTEAU HERRIOT | Director, Chief Executive Officer, 10% Owner | Exercise of derivative | 4,660 | $4.95 | $23.1K | filing |
| 2026-08-07 | 2026-08-05 | 2 | TABUTEAU HERRIOT | Director, Chief Executive Officer, 10% Owner | Exercise of derivative | 45,004 | $0.00 | — | filing |
| 2026-08-07 | 2026-08-05 | 2 | TABUTEAU HERRIOT | Director, Chief Executive Officer, 10% Owner | Open market sale | 45,004 | $212.01 | $9.5M | filing |
| 2026-08-07 | 2026-08-06 | 1 | TABUTEAU HERRIOT | Director, Chief Executive Officer, 10% Owner | Open market sale | 4,660 | $213.95 | $997K | filing |
| 2026-08-07 | 2026-08-05 | 2 | TABUTEAU HERRIOT | Director, Chief Executive Officer, 10% Owner | Exercise of derivative | 45,004 | $4.95 | $222.8K | filing |
| 2026-08-07 | 2026-08-06 | 1 | TABUTEAU HERRIOT | Director, Chief Executive Officer, 10% Owner | Exercise of derivative | 4,660 | $0.00 | — | filing |